Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (May 2025)
Ozempic has become a phenomenon, with $17 billion in sales projected for 2024, solidifying Novo Nordisk's position as a leading manufacturer in the obesity drug market.